Nisa Investment Advisors LLC Sells 12,823 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Nisa Investment Advisors LLC reduced its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 88.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,703 shares of the company's stock after selling 12,823 shares during the period. Nisa Investment Advisors LLC's holdings in Option Care Health were worth $40,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. FMR LLC boosted its position in Option Care Health by 134.0% during the third quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after purchasing an additional 4,304,896 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock valued at $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Wellington Management Group LLP boosted its holdings in Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after buying an additional 1,328,326 shares during the period. Geneva Capital Management LLC purchased a new position in Option Care Health in the 3rd quarter valued at approximately $24,679,000. Finally, Westfield Capital Management Co. LP raised its holdings in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after acquiring an additional 599,589 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business's stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company's stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.64% of the company's stock.

Option Care Health Price Performance

OPCH traded up $0.22 on Tuesday, reaching $30.90. The company had a trading volume of 1,561,956 shares, compared to its average volume of 1,999,789. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The company has a market cap of $5.26 billion, a price-to-earnings ratio of 25.97, a P/E/G ratio of 2.19 and a beta of 1.35. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business has a 50 day simple moving average of $25.46 and a 200 day simple moving average of $27.87.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on OPCH. Barrington Research lifted their price target on Option Care Health from $32.00 to $33.00 and gave the company an "outperform" rating in a research report on Tuesday, January 14th. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Truist Financial decreased their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.